Results 21 to 30 of about 571 (112)

Long-term control of refractory acrodermatitis continua of Hallopeau with subcutaneous spesolimab: A case report [PDF]

open access: yesJAAD Case Reports
Jan Nicolai Wagner, MD   +4 more
doaj   +2 more sources

Spesolimab Rapidly Resolved Capillary Leak Syndrome Associated with Generalized Pustular Psoriasis

open access: yesActa Dermato-Venereologica
Yoshiki Okada   +4 more
doaj   +2 more sources

The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab

open access: yesFrontiers in Immunology, 2023
Generalized pustular psoriasis (GPP) is a rare, chronic, inflammatory skin disorder characterized by recurrent flares associated with skin erythema, desquamation, and widespread superficial sterile pustules, which may be severe (“lakes of pus”). Systemic
Jason E. Hawkes   +2 more
doaj   +1 more source

First experiences in real clinical practice treating a patient with generalised pustular psoriasis with Spesolimab

open access: yesJEADV Clinical Practice, 2023
Generalised pustular psoriasis is a rare, unpredictable, and sometimes severe subtype of psoriasis whose treatment is hampered by a lack of consensus and standardised therapeutic guidelines.
Aurora Fernández‐Galván   +7 more
doaj   +1 more source

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

open access: yesBMJ Open, 2021
Introduction Generalized pustular psoriasis (GPP) is a rare, potentially life-threatening disease characterised by recurrent flares of widespread neutrophilic aseptic skin pustular eruption. Despite the availability of approved biologics for GPP in Japan,
Hamida Turki   +14 more
doaj   +1 more source

Generalized Pustular Psoriasis with Breast Cancer Successfully Treated with Spesolimab Causing Neutrophilia: A Case Report [PDF]

open access: yesActa Dermato-Venereologica
Rina Obata   +4 more
doaj   +2 more sources

Spesolimab for a child with generalized pustular psoriasis accompanied epilepsy and hyperactivity

open access: yesJournal of Dermatological Treatment
Objectives To evaluate the therapeutic efficacy and safety of spesolimab in pediatric GPP treatment.Methods We report a 10-year-old male pediatric patient with refractory Generalized Pustular Psoriasis (GPP), comorbid epilepsy, hyperactivity ...
Yudan Wang   +6 more
doaj   +1 more source

Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study [PDF]

open access: yesActa Dermato-Venereologica
Yoshiki Okada   +4 more
doaj   +2 more sources

S1 Guideline: Therapy of generalized pustular psoriasis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner   +17 more
wiley   +1 more source

Real-world efficacy of spesolimab in treating generalized pustular psoriasis flares: A case series review

open access: yesDermatologica Sinica
This case series review examines the efficacy of spesolimab in managing generalized pustular psoriasis (GPP) flares, including those exacerbated by coronavirus disease 2019 (COVID-19) vaccination.
Chun-Bing Chen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy